Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03906578

Effects of a Probiotic in Hypertension

Effect of a Probiotic on Blood Pressure in Low-to-moderate Risk Grade 1 Hypertension - a Randomized Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

High blood pressure is a major risk factor for cardiovascular events, including stroke, heart and kidney failure. Typical anti-hypertensive drugs target vessels, the kidneys or the heart. Here we propose a randomized, placebo-controlled study to test the blood pressure-lowering effect of a probiotic in 110 patients with grade 1 hypertension. In addition, we will investigate glucose variability, fecal bacterial metabolome, peripheral blood effector T cell frequencies (%) and health-related quality of life.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVivomixx®Microbiotic food supplement with L. paracasei, L. plantarum, L. acidophilus, L. delbrueckii, B. longum, B. infantis, B. breve, S. thermophilus
OTHERPlaceboPlacebo with similar appearance to probiotic

Timeline

Start date
2019-09-02
Primary completion
2024-09-01
Completion
2025-09-01
First posted
2019-04-08
Last updated
2024-07-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03906578. Inclusion in this directory is not an endorsement.